Interleukin-2 Immunotherapy early after autologous stem cell transplantation for malignantnlmyphomas - a dose escalation study. | Charles Explorer

Interleukin-2 Immunotherapy early after autologous stem cell transplantation for malignantnlmyphomas - a dose escalation study.

Publication at Faculty of Physical Education and Sport |

1999

Abstract

NHL, transplantation, lymphoma, Hodgkin, interleukin-2, immunotherapy, ASCT.

People